The Australian Government acquires another 10 million doses of Pfizer and BioNTech's vaccine and Russia announces promising phase 3 trial results. [ + ]

Researchers have shown that synthetic cannabidiol — better known as CBD — can kill the bacteria responsible for gonorrhoea, meningitis and Legionnaires' disease. [ + ]

The global COVID-19 pandemic is posing unprecedented challenges for laboratories as they race to meet the demand for accurate, large-scale testing in a short amount of time. [ + ]

NVX-CoV2373, a protein-based COVID-19 vaccine candidate, has demonstrated efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK. [ + ]

US scientists have miniaturised the optical components required to cool atoms down to a few thousandths of a degree Celsius above absolute zero. [ + ]

The Therapeutic Goods Administration (TGA) has granted provisional approval to Pfizer Australia for its COVID-19 vaccine, developed in partnership with BioNTech. [ + ]

Scientists have studied the phenomenon of the placebo effect in the context of nausea, and identified specific proteins that correlate with its favourable impact. [ + ]

Climate change is accelerating at an alarming pace — and the impacts are hard to ignore. Let's take a look at some changes to our ocean. [ + ]

Dr Thaddeus Stappenbeck dispels fears about the new generation of vaccines and explains that they cannot alter your DNA or give you COVID-19. [ + ]

Japanese scientists have found a way to measure both fluorescence intensity and lifetime. [ + ]

The survival of all species — including ours — is being threatened by loss of biodiversity and accelerating climate change in the coming decades, scientists say. [ + ]

A newly developed compound starves cancer cells by attacking their 'power plants', by preventing the genetic information within mitochondria from being read. [ + ]

Scientists have developed insulin nanoparticles that may one day become the basis for an oral medicine — and an alternative to insulin injections for diabetic patients. [ + ]

Researchers have developed a scalable and flexible microreactor that will not only make reactions with Grignard reagents faster and safer, but should also yield a purer product. [ + ]

Prime Minister Scott Morrison says the first groups are expected to receive a jab as early as the middle of the month. [ + ]